Evidence map›Paper›PMID 34632228›Full record

ArticleACS omega2021

Au Nanoflowers for Catalyzing and In Situ Surface-Enhanced Raman Spectroscopy Monitoring of the Dimerization of

Jingwen Ba, Yandong Han, Xiaoyu Zhang, Lijuan Zhang, Shuhan Hui, Zhenzhen Huang, Wensheng Yang

Open access · goldAbstract read
In one paragraph

Article in ACS omega, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 53% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 10 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Jingwen BaState Key Laboratory of Inorganic Synthesis and Preparative Chemistry, College of Chemistry, Jilin University, Changchun 130012, China.
Yandong HanInstitute of Molecular Plus, Tianjin University, Tianjin 300072, China.
Xiaoyu ZhangState Key Laboratory of Inorganic Synthesis and Preparative Chemistry, College of Chemistry, Jilin University, Changchun 130012, China.
Lijuan ZhangState Key Laboratory of Inorganic Synthesis and Preparative Chemistry, College of Chemistry, Jilin University, Changchun 130012, China.
Shuhan HuiState Key Laboratory of Inorganic Synthesis and Preparative Chemistry, College of Chemistry, Jilin University, Changchun 130012, China.
Zhenzhen HuangState Key Laboratory of Inorganic Synthesis and Preparative Chemistry, College of Chemistry, Jilin University, Changchun 130012, China.ORCID https://orcid.org/0000-0002-9300-5219
Wensheng YangState Key Laboratory of Inorganic Synthesis and Preparative Chemistry, College of Chemistry, Jilin University, Changchun 130012, China.ORCID https://orcid.org/0000-0003-2674-6751
Jilin University · CNTianjin University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this work, we demonstrated a facile approach for fabrication of Au nanoflowers (Au NFs) using an amino-containing organosilane, 3-aminopropyltriethoxysilane (APTES), as a shape-directing agent. In this approach, the morphology of the Au particles evolved from sphere-like to flower-like with increasing the concentration of APTES, accompanied by a red shift in the localized surface plasmon resonance peak from 520 to 685 nm. It was identified that the addition of APTES is profitable to direct the preferential growth of the (111) plane of face-centered cubic gold and promote the formation of anisotropic Au NFs. The as-prepared Au NFs, with APTES on their surface, presented effective catalytic and surface-enhanced Raman scattering (SERS) performances, as evidenced by their applications in catalyzing the dimerization of

Identifiers

PMID34632228
PMCPMC8495860
OpenAlexW3200335978

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.